PF-07329640

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-07329640, covering 2024-11-06 to 2024-11-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination [Phase 1]

See pricing